DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Oriental Insurance hopes to turn corner in FY27 assisted by NSE stake dilution

CNBC-TV18 1 hr ago·13 Sept 2026, 9:29 am

Oriental Insurance is planning to dilute a small portion of its stake in the National Stock Exchange (NSE) through an upcoming IPO. The company will offer approximately 49.57 lakh shares, which represents a minor portion of its total holding. This move is part of the insurer's broader strategy to strengthen its financial position and improve its capital adequacy.

For investors, this development signals a potential turning point for the insurer. By monetizing a small stake in a key market infrastructure company, Oriental Insurance aims to bolster its balance sheet. This could enhance its ability to underwrite policies and manage risks more effectively in the coming fiscal year.

Investors should monitor the proceeds from this stake sale and how Oriental Insurance plans to utilize the funds. The successful execution of this move could signal a recovery in the company's financial health, but the broader impact will depend on its overall operational performance in FY27.